Transparency drop a ‘wakeup call’

Transparency reporting by the pharmaceutical industry is in decline, warn Australian researchers who are calling for mandatory disclosure And increased prescribing of unnecessary and costly medicines is one significant potential consequence of pharma company spending on events about their products, and payments to individual health professionals, health consumer groups and third parties such as hospitals,